Global Veterinary Surgical Instruments Market to Reach $2.8 Billion by 2030
The global market for Veterinary Surgical Instruments estimated at US$2 Billion in the year 2022, is projected to reach a revised size of US$2.8 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2022-2030. Handheld Devices, one of the segments analyzed in the report, is projected to record a 4.3% CAGR and reach US$1.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Sutures, Staplers & Accessories segment is readjusted to a revised 5.1% CAGR for the next 8-year period.The U.S. Market is Estimated at $539.2 Million, While China is Forecast to Grow at 7.4% CAGR
The Veterinary Surgical Instruments market in the U.S. is estimated at US$539.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$587.1 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.3% and 4.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$374.3 Million by the year 2030.Select Competitors (Total 46 Featured) -
- Antibe Therapeutics, Inc.
- B. Braun Vet Care GmbH
- Dre Veterinary, Inc.
- Ethicon US LLC
- Germed USA, Inc.
- Im3 Inc.
- Integra Life Sciences Corporation
- Jorgen Kruuse A/S
- Jorgensen Laboratories
- Medtronic PLC
- Neogen Corporation
- Sklar Instruments
- Smiths Group PLC
- Steris Corporation
- Surgical Direct
- Surgical Holdings
- World Precision Instruments
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Antibe Therapeutics, Inc.
- B. Braun Vet Care GmbH
- Dre Veterinary, Inc.
- Ethicon US LLC
- Germed USA, Inc.
- Im3 Inc.
- Integra Life Sciences Corporation
- Jorgen Kruuse A/S
- Jorgensen Laboratories
- Medtronic PLC
- Neogen Corporation
- Sklar Instruments
- Smiths Group PLC
- Steris Corporation
- Surgical Direct
- Surgical Holdings
- World Precision Instruments
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 196 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 2 Billion |
Forecasted Market Value ( USD | $ 2.8 Billion |
Compound Annual Growth Rate | 4.3% |
Regions Covered | Global |